Deutsche Bank
MATN

Deutsche Bank’s Mateon Therapeutics, Inc. MATN Stock Holding History

Deutsche Bank’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9
Closed – – 5240
2016
Q3 		$0 Buy
9
+1
+13% +$1 ﹤0.01% 5454
2016
Q2 		$0 Buy
+8
New +$6 ﹤0.01% 5502

Other funds holding MATN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Deutsche Bank's MATN Position: Q4 2016 in Review

Deutsche Bank sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 9 shares.

Deutsche Bank first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Deutsche Bank reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Deutsche Bank sold 9 Mateon Therapeutics, Inc. shares in Q4 2016.
  • Deutsche Bank first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Deutsche Bank's Mateon Therapeutics, Inc. position peaked at $0 in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.